If the choice is between phentermine and nothing, phentermine wins every time
Semaglutide mimics the GLP-1 hormone, which controls blood sugar and appetite
Together, these companies account for the majority of GLP-1 prescriptions being written virtually today, and represent the full spectrum of approachesfrom clinically rigorous, wrap-around care models to high-volume pill-pushing platforms
The STEP (Semaglutide Treatment Effect in People with Obesity) trials represent the most comprehensive safety data available for semaglutide at the 2.4 mg weight loss dose
By mimicking the GLP-1 hormone, slowing stomach emptying, and reducing glucagon release, it provides multiple benefits for people with type 2 diabetes and those struggling with weight management
But they deserve discussion because some offer genuine, if modest, benefits, and many people want non-pharmaceutical options as a starting point or complement